Feb 27, 2024 / 01:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome everyone to the Ligand Fourth Quarter 2023 earnings webcast.
At this time, all lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. If you'd like to ask a question during this time, simply press the star followed by the number one on your telephone keypad. If you'd like to withdraw your question, please press the star followed by the one.
Once again. Thank you. I will now hand the call over to Teva Aspen dozer, Chief Financial Officer. You may begin your conference.
Octavio Espinoza - Ligand Pharmaceuticals Inc - Chief Financial Officer
Hello, everyone, and welcome to our earnings call for the fourth quarter and year-end 2023. During the call today, we will review the financial results we released prior to today's market opens and offer commentary on our partnered pipeline and business development activity, after which we will host a question and answer session. Our earnings release can be found in
Q4 2023 Ligand Pharmaceuticals Inc Earnings Call Transcript
Feb 28, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers